|
Ustekinumab Clinical Trials
3 actively recruiting trials across 2 locations
No change since May 2026
Also known as: STELARA, Stelara
Pipeline
Phase 2: 1
Top Sponsors
- University of California, San Diego1
- Swiss Dermatology Network for Targeted Therapies1
- M.D. Anderson Cancer Center1
Indications
- Arthritis2
- Psoriasis2
- Psoriatic Arthritis1
- Crohn Disease1
- Pregnancy1
Other1 trial
La Jolla, California1 trial
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
University of California, San Diego
Houston, Texas1 trial
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
The University of Texas M. D. Anderson Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.